SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-004326
Filing Date
2023-01-17
Accepted
2023-01-17 17:24:37
Documents
18
Period of Report
2023-01-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm233601d1_8k.htm   iXBRL 8-K 37183
2 EXHIBIT 3.1 tm233601d1_ex3-1.htm EX-3.1 3554
3 EXHIBIT 99.1 tm233601d1_ex99-1.htm EX-99.1 18454
7 GRAPHIC tm233601d1_ex99-1img001.jpg GRAPHIC 4456
8 GRAPHIC tm233601d1_ex3-1img01.jpg GRAPHIC 99516
9 GRAPHIC tm233601d1_ex3-1img02.jpg GRAPHIC 245060
10 GRAPHIC tm233601d1_ex3-1img03.jpg GRAPHIC 36153
  Complete submission text file 0001104659-23-004326.txt   780757

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA idra-20230112.xsd EX-101.SCH 3042
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20230112_lab.xml EX-101.LAB 35156
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20230112_pre.xml EX-101.PRE 23035
12 EXTRACTED XBRL INSTANCE DOCUMENT tm233601d1_8k_htm.xml XML 3884
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 23532300
SIC: 2836 Biological Products, (No Diagnostic Substances)